Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR5 | Q9H228 | 5/20 | 0.32 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22255656 | 0.96 | NQO1 (0.31) | GPR84NQO1NQO2 | |
| SCHEMBL22255653 | 0.96 | S1PR5 (0.33) | S1PR5S1PR4GPR84NQO1NQO2 | |
| SCHEMBL22255687 | 0.91 | S1PR5 (0.34) | S1PR5S1PR4GPR84HSD17B1HSD17B2 | |
| SCHEMBL21203307 | 0.91 | NQO1 (0.32) | GPR84NQO1NQO2 | |
| SCHEMBL22255655 | 0.91 | NQO1 (0.32) | GPR84NQO1NQO2 | |
| SCHEMBL21206078 | 0.91 | NQO1 (0.32) | GPR84NQO1NQO2 | |
| SCHEMBL22255618 | 0.90 | F9 (0.33) | NQO1NQO2 | |
| SCHEMBL23225315 | 0.90 | HSD17B1 (0.35) | S1PR5S1PR4HSD17B1HSD17B2 | |
| SCHEMBL23225083 | 0.90 | HSD17B1 (0.35) | S1PR5S1PR4HSD17B1HSD17B2 | |
| SCHEMBL22255352 | 0.90 | HSD17B1 (0.35) | S1PR5S1PR4HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235297-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC18A2, SLC18A1, MAOA | S1PR5 3891/4885S1PR4 3725/4885GPR84 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.